Immunosuppressive drug therapy as a potentiator of skin tumours in five patients with lymphoma.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000139:chemically induced*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D002699:Chlorambucil / Q000009:adverse effects; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000139:chemically induced*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000139:chemically induced*
D000970:Antineoplastic Agents; D002699:Chlorambucil